跳至主要内容
临床试验/DRKS00033344
DRKS00033344招募中不适用

Multicentric, uncontrolled, prospective post market clinical follow up (PMCF) study to assess symptom relief by the class I medical device GeloTonsil® Gurgelgel and its tolerability in patients with acute pharyngitis.

G. Pohl-Boskamp GmbH & Co. KG0 个研究点目标入组 500 人开始时间: 2024年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Signed informed consent form and data protection form
  • Patient is aged = 18 years
  • Patients is suffering an acute pharyngitis with throat pain
  • Patient is read, write and speak German.

排除标准

  • -Contraindications for GeloTonsil® (Allergy or hypersensitivity to any of the ingredients, current application of other mouth and throat medicines and the lack of ability to gargle safely)
  • -Pregnancy or breastfeeding
  • -Sore throat persisting longer than 5 days
  • -Centor score = 3 (probability to find group A streptococcal infections (GAS) in throat swab – fever >38°, absent from coughing, swollen anterior cervical lymph nodes, Tonsil exudates; one point for each accordance)
  • -Patients requiring antibiotic treatment for any condition at study entry
  • -Parallel participation in another study, participation in a study within less than 6 weeks prior to study entry, or previous participation in this same study
  • -Employee or direct relative of an employee of the investigational site or of the study sponsor
  • -Known to be, or suspected of being unable to comply with the study protocol (e.g. no permanent address, history of drug abuse, known to be non-compliant or presenting an unstable psychiatric history)
  • -Legal incapacity and / or other circumstances rendering the patient unable to understand the nature, scope and possible impact of the study

研究者

相似试验